CD28, CTLA-4 and their ligands: who does what and to whom?

David Sansom

Immunology and Immunotherapy

Research output: Contribution to journal › Article

174 Citations (Scopus)

Original language	English
Pages (from-to)	169-77
Number of pages	9
Journal	Immunology
Volume	101
Issue number	2
DOIs	https://doi.org/10.1046/j.1365-2567.2000.00121.x
Publication status	Published - 1 Oct 2000

Access to Document

10.1046/j.1365-2567.2000.00121.x

Cite this

@article{0c6bc187ad044eadb0195d90cb91bc09,

title = "CD28, CTLA-4 and their ligands: who does what and to whom?",

author = "David Sansom",

year = "2000",

month = oct,

day = "1",

doi = "10.1046/j.1365-2567.2000.00121.x",

language = "English",

volume = "101",

pages = "169--77",

journal = "Immunology",

issn = "1365-2567",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - CD28, CTLA-4 and their ligands: who does what and to whom?

AU - Sansom, David

PY - 2000/10/1

Y1 - 2000/10/1

UR - http://www.scopus.com/inward/record.url?scp=0033770215&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2567.2000.00121.x

DO - 10.1046/j.1365-2567.2000.00121.x

M3 - Article

C2 - 11012769

SN - 1365-2567

VL - 101

SP - 169

EP - 177

JO - Immunology

JF - Immunology

IS - 2

ER -